본문 바로가기

Clinical Implications of Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma: Cancer-Draining Blood Versus Peripheral Blood

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
CANCERS16(16) · 2024
피인용
Web of Science 2Scopus 5
FWCI (Scopus)
0.56
JCR IF
JCR 2023 4.5
ISSN
2072-6694

저자

  1. 주동찬제1저자Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
  2. 김광하교신저자Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
  3. 이호석Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
  4. 박수진Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
  5. 이문원Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea
  6. 이봉은Pusan Natl Univ Hosp, Biomed Res Inst, Busan 49241, South Korea

초록

Circulating tumor cells (CTCs) in cancer-draining veins have diagnostic and prognostic value. However, studies on esophageal squamous cell carcinoma (ESCC) are limited. This study aimed to compare CTCs obtained from different sampling sites (peripheral vein vs. cancer-draining azygos vein) and to investigate their association with the clinicopathological characteristics of ESCC patients. Blood samples were collected preoperatively from both veins in 40 ESCC patients at Pusan National University Hospital from June 2020 to April 2022. CTCs were detected using a centrifugal microfluidic method with fluid-assisted separation. CTCs and TWIST (+) CTCs were detected more frequently in the azygos vein blood than in the peripheral vein blood; however, the difference was not statistically significant (85.0% [34/40] vs. 77.5% [31/40], p = 0.250 and 82.5% [33/40] vs. 75.0% [30/40], p = 0.586, respectively). CTC and TWIST (+) CTC counts were significantly higher in the azygos vein blood than in the peripheral vein blood (7 vs. 3, p < 0.001, and 6 vs. 2, p < 0.001, respectively). CTCs and TWIST (+) CTCs from peripheral and azygos veins showed no association with clinicopathological characteristics. Further large-scale studies are needed to clarify their role as predictive biomarkers for prognosis and chemotherapy responses in ESCC patients.

키워드

azygos veincirculating tumor cellsesophageal neoplasmssquamous cell carcinomaTWISTPULMONARY VENOUS-BLOODVEINRESECTIONTOOL

식별자

Scopus EID
2-s2.0-85202488394
WoS UID
001306918200001